Company intelligence / Profile preview

MicroGen Biotech

Carlow, Leinster, Irelandmicrogendx.com ↗

Ownership: Private
Development stage: Commercial

Overview

MicroGen Biotech has developed a patented microbiome technology that uses selected microbial consortia to reduce heavy metal uptake by crops, improve soil health, increase crop yields, and degrade organic pollutants. Their products have demonstrated the ability to lower toxic pollutant levels in food by up to 50%. The company is active globally with a particular focus on China and the US.

Therapeutic areas: Other
Modalities: Microbial therapyLive biotherapeutic product therapy
Industry: Agriculture & AgTech

Partnerships

Strategic alliances with Chinese soil remediation companies including China Energy Conservation and Environment Protection GroupParticipation in THRIVE AgTech accelerator program at Western Growers Center for Innovation & Technology

Beyond the preview

Go deeper on MicroGen Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroGen Biotech.

Explore the full profile